Showing results (1401-1410 of 1,594) with videos related to
Sort By:
Pageof 160
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 31, 2025
First-Line Sacituzumab Govitecan Plus Pembrolizumab in Metastatic NSCLC: PD-L1 TPS Less Than 50% and More Than or Equal to 50% Cohorts of the EVOKE-02 StudyMartin Reck, Jyoti D Patel, Jhanelle E Gray, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2023
Phase II Study of Docetaxel and Trametinib in Patients with KRAS Mutation Positive Recurrent Non-Small Cell Lung Cancer (NSCLC; SWOG S1507, NCT-02642042)Shirish M Gadgeel, Jieling Miao, Jonathan W Riess, et al.Oecologia|January 8, 2021
Is a drought a drought in grasslands? Productivity responses to different types of droughtCharles J W Carroll, Ingrid J Slette, Robert J Griffin-Nolan, et al.The Lancet. Oncology|October 12, 2019
Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 studyRina Hui, Mustafa Özgüroğlu, Augusto Villegas, et al.International Journal of Environmental Research and Public Health|June 7, 2014
Are we driving our kids to unhealthy habits? Results of the active healthy kids Canada 2013 report card on physical activity for children and youthCasey E Gray, Richard Larouche, Joel D Barnes, et al.Journal of Clinical Immunology|December 23, 2019
Diversity of XMEN Disease: Description of 2 Novel Variants and Analysis of the Lymphocyte PhenotypeElizabeth M Klinken, Paul E Gray, Bethany Pillay, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 19, 2015
Effect of Condom Use on Per-act HSV-2 Transmission Risk in HIV-1, HSV-2-discordant CouplesAmalia S Magaret, Andrew Mujugira, James P Hughes, et al.Oncotargets and Therapy|September 19, 2017
Safety, pharmacokinetics, and pharmacodynamics of oral omaveloxolone (RTA 408), a synthetic triterpenoid, in a first-in-human trial of patients with advanced solid tumorsBen C Creelan, Dmitry I Gabrilovich, Jhanelle E Gray, et al.Nature Genetics|May 23, 2018
Multiplex assessment of protein variant abundance by massively parallel sequencingKenneth A Matreyek, Lea M Starita, Jason J Stephany, et al.EMBO Reports|May 11, 2017
The chromatin remodelling factor ATRX suppresses R-loops in transcribed telomeric repeatsDiu Tt Nguyen, Hsiao Phin J Voon, Barbara Xella, et al.Pageof 160